Article Details

Expansion of Opaganib Global Phase 2/3 COVID-19 Study Planned for Patients With Severe ...

Retrieved on: 2021-02-24 16:52:30

Tags for this article:

Click the tags to see associated articles and topics

Expansion of Opaganib Global Phase 2/3 COVID-19 Study Planned for Patients With Severe .... View article details on hiswai:

Excerpt

In a press release, RedHill Biopharma announced an expansion of the study will require adjustments to the study's protocol, which will be based on the ...

Article found on: www.pharmacytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo